Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis

Psychiatry Research

Volumn 230, Issue 3, 2015, Pages 878-884

  Buchy, Lisa ^a   Seidman, Larry J ^b   Cadenhead, Kristin S ^c   Cannon, Tyrone D ^d   Cornblatt, Barbara A ^e   McGlashan, Thomas H ^f   Perkins, Diana O ^g,h   Stone, William ^b   Tsuang, Ming T ^c   Walker, Elaine F ⁱ   Woods, Scott W ^e   Bearden, Carrie E ^j   Mathalon, Daniel H ^k   Addington, Jean ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d YALE UNIVERSITY   (United States)

^e ZUCKER HILLSIDE HOSPITAL   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ EMORY UNIVERSITY   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Age at onset; Alcohol; Cannabis; IQ; Prodrome; Schizophrenia

Indexed keywords

CANNABIS;

ADULT; ARTICLE; BRAIN FUNCTION; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; HIGH RISK POPULATION; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; YOUNG ADULT; ADOLESCENT; CANNABIS SMOKING; CHILD; COGNITION; DRINKING BEHAVIOR; INTELLIGENCE; INTELLIGENCE TEST; PHYSIOLOGY; PSYCHOLOGY; RISK;

ADOLESCENT; ADULT; AGE OF ONSET; ALCOHOL DRINKING; CHILD; COGNITION; FEMALE; HUMANS; INTELLIGENCE; INTELLIGENCE TESTS; MALE; MARIJUANA SMOKING; PSYCHOTIC DISORDERS; RISK; YOUNG ADULT;

EID: 84949008811     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.11.033     Document Type: Article

References (48)

1. Addington J., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Addington J.A., Cannon T.D. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr. Res. 2012, 142(1-3):77-82.
2. Addington J., Case N., Saleem M.M., Auther A.M., Cornblatt B.A., Cadenhead K.S. Substance use in clinical high risk for psychosis: a review of the literature. Early Interv. Psychiatry 2014, 8(2):104-112.
3. Allen D.N., Goldstein G., Aldarondo F. Neurocognitive dysfunction in patients diagnosed with schizophrenia and alcoholism. Neuropsychology 1999, 13(1):62-68.
4. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T.E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002, 325(7374):1212-1213.
5. Auther A.M., Cadenhead K.S., Carrion R.E., Addington J., Bearden C.E., Cannon T.D., McGlashan T.H., Perkins D.O., Seidman L., Tsuang M., Walker E.F., Woods S.W., Cornblatt B.A. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatr. Scand. 2015, 132(1):60-68.
6. Bahorik A.L., Newhill C.E., Eack S.M. Neurocognitive functioning of individuals with schizophrenia: using and not using drugs. Schizophr. Bull. 2014, 40(4):856-867.
7. Benaiges I., Serra-Grabulosa J.M., Prat G., Adan A. Executive functioning in individuals with schizophrenia and/or cocaine dependence. Hum. Psychopharmacol. 2013, 28(1):29-39.
8. Buchy L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R., Bearden C.E., Mathalon D.H., Addington J. Substance use in individuals at clinical high risk of psychosis. Psychol. Med. 2015, 45(11):2275-2284.
9. Buchy L., Cannon T., Lyngberg K., Cadenhead K., Cornblatt B., McGlashan T., Perkins D., Seidman L., Tsuang M., Walker E., Woods S.W., Bearden C., Mathalon D.H., Addington J. Impact of Cannabis use on Thalamic Connectivity in Youth at Clinical High Risk of Psychosis 2015, 251S. Biological Psychiatry, Toronto, ON.
10. Cantor-Graae E., Nordstrom L.G., McNeil T.F. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr. Res. 2001, 48(1):69-82.
11. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry 2005, 57(10):1117-1127.
12. de Leon J., Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 2005, 76(2-3):135-157.
13. Dekker N., Schmitz N., Peters B.D., van Amelsvoort T.A., Linszen D.H., de Haan L. Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry Res. 2010, 181(1):51-56.
14. Drake R.E., Mueser K., McHugo G. Clinical rating scales. Outcomes Assessment in Clinical Practice 1996, 113-116. Williams and Wilkins, Baltimore. L. Sederer, B. Dickey (Eds.).
15. Ferraro L., Russo M., O'Connor J., Wiffen B.D., Falcone M.A., Sideli L., Gardner-Sood P., Stilo S., Trotta A., Dazzan P., Mondelli V., Taylor H., Friedman B., Sallis H., La Cascia C., La Barbera D., David A.S., Reichenberg A., Murray R.M., Di Forti M. Cannabis users have higher premorbid IQ than other patients with first onset psychosis. Schizophr. Res. 2013, 150(1):129-135.
16. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 1998. Structured clinical interview for DSM-IV patient edition (SCID-I/P V and SCID-I/NP Version 2.0). Biometric Research Department, New York.
17. Fowler I.L., Carr V.J., Carter N.T., Lewin T.J. Patterns of current and lifetime substance use in schizophrenia. Schizophr. Bull. 1998, 24(3):443-455.
18. Fusar-Poli P., Bonoldi I., Yung A.R., Borgwardt S., Kempton M.J., Valmaggia L., Barale F., Caverzasi E., McGuire P. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch. Gen. Psychiatry 2012, 69(3):220-229.
19. Gurillo P., Jauhar S., Murray R.M., MacCabe J.H. Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry 2015, 2(8):718-725.
20. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U., van Os J. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005, 330(7481):11.
21. Jockers-Scherubl M.C., Wolf T., Radzei N., Schlattmann P., Rentzsch J., Gomez-Carrillo de Castro A., Kuhl K.P. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31(5):1054-1063.
22. Joyal C.C., Halle P., Lapierre D., Hodgins S. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia. Schizophr. Res. 2003, 63(3):297-299.
23. Kuepper R., van Os J., Lieb R., Wittchen H.U., Hofler M., Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 2011, 342:d738.
24. Leeson V.C., Harrison I., Ron M.A., Barnes T.R., Joyce E.M. The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophr. Bull. 2012, 38(4):873-880.
25. Loberg E.M., Hugdahl K. Cannabis use and cognition in schizophrenia. Front. Hum. Neurosci. 2009, 3:53.
26. Manning V., Betteridge S., Wanigaratne S., Best D., Strang J., Gossop M. Cognitive impairment in dual diagnosis inpatients with schizophrenia and alcohol use disorder. Schizophr. Res. 2009, 114(1-3):98-104.
27. McGlashan T.H., Walsh B.C., Woods S.W. The Psychosis Risk Syndrome: Handbook for Diagnosis and Follow-Up 2010, Oxford University Press, New York, NY.
28. Meyer E.C., Carrion R.E., Cornblatt B.A., Addington J., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R., Seidman L.J., NAPLS group. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophr. Bull. 2014, 40(6):1452-1461.
29. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370(9584):319-328.
30. Morisano D., Wing V.C., Sacco K.A., Arenovich T., George T.P. Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls. Am. J. Addict. 2013, 22(1):46-53.
31. Potvin S., Joyal C.C., Pelletier J., Stip E. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophr. Res. 2008, 100(1-3):242-251.
32. Rabin R.A., Zakzanis K.K., George T.P. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophr. Res. 2011, 128(1-3):111-116.
33. Rodriguez-Sanchez J.M., Ayesa-Arriola R., Mata I., Moreno-Calle T., Perez-Iglesias R., Gonzalez-Blanch C., Perianez J.A., Vazquez-Barquero J.L., Crespo-Facorro B. Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophr. Res. 2010, 124(1-3):142-151.
34. Schnell T., Koethe D., Daumann J., Gouzoulis-Mayfrank E. The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacol. (Berl.) 2009, 205(1):45-52.
35. Serper M.R., Bergman A., Copersino M.L., Chou J.C., Richarme D., Cancro R. Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients. Psychiatry Res. 2000, 93(1):21-32.
36. Serper M.R., Copersino M.L., Richarme D., Vadhan N., Cancro R. Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients. J. Subst. Abus. 2000, 11(2):205-213.
37. Smelson D.A., Davis C.W., Eisenstein N., Engelhart C., Williams J., Losonczy M.F., Ziedonis D. Cognitive disparity in schizophrenics with and without cocaine dependency. J. Subst. Abus. Treat. 2003, 24(1):75-79.
38. Solowij N., Michie P.T. Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?. J. Psychiatry Neurosci. 2007, 32(1):30-52.
39. Stirling J., Lewis S., Hopkins R., White C. Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophr. Res. 2005, 75(1):135-137.
40. Tosato S., Lasalvia A., Bonetto C., Mazzoncini R., Cristofalo D., De Santi K., Bertani M., Bissoli S., Lazzarotto L., Marrella G., Lamonaca D., Riolo R., Gardellin F., Urbani A., Tansella M., Ruggeri M., Group P.-V. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS). J. Psychiatry Res. 2013, 47(4):438-444.
41. Valmaggia L.R., Day F.L., Jones C., Bissoli S., Pugh C., Hall D., Bhattacharyya S., Howes O., Stone J., Fusar-Poli P., Byrne M., McGuire P.K. Cannabis use and transition to psychosis in people at ultra-high risk. Psychol. Med. 2014, 44(12):2503-2512.
42. van der Meer F.J., Meijer J.H., Meijer C.J., van den Brink W., Velthorst E., Genetic R., Outcome of Psychosis I. Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls. Psychol. Med. 2014, 44(9):1901-1911.
43. Wechsler D. Wechsler Abbreviated Scale of Intelligence 1999, The Psychological Corporation, San Antonio, TX.
44. Wing V.C., Bacher I., Sacco K.A., George T.P. Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status. Psychiatry Res. 2011, 188(3):320-326.
45. Woodberry K.A., Seidman L.J., Giuliano A.J., Verdi M.B., Cook W.L., McFarlane W.R. Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence. Schizophr. Res. 2010, 123(2-3):188-198.
46. Yip S.W., Sacco K.A., George T.P., Potenza M.N. Risk/reward decision-making in schizophrenia: a preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance. Schizophr. Res. 2009, 110(1-3):156-164.
47. Yucel M., Bora E., Lubman D.I., Solowij N., Brewer W.J., Cotton S.M., Conus P., Takagi M.J., Fornito A., Wood S.J., McGorry P.D., Pantelis C. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr. Bull. 2012, 38(2):316-330.
48. Zammit S., Lewis G., Dalman C., Allebeck P. Examining interactions between risk factors for psychosis. Br. J. Psychiatry 2010, 197(3):207-211.